Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An Online Nutrition Education Program Targeting Intentions and Related Determinants Towards Dietary Supplement Use: An Application of the Theory of Planned Behavior. | Nutrients | 2025 | 39940414 | PubTator, text mining | PubMed |
| SRF/SLC31A1 signaling promotes cuproptosis induced by celastrol in NSCLC. | Int Immunopharmacol | 2025 | 39930648 | PubTator, text mining | PubMed |
| Intentions of hospital pharmacists to use digital technology in their daily practice: a cross-sectional survey using the Theory of Planned Behaviour. | Int J Clin Pharm | 2025 | 39928066 | PubTator, text mining | PubMed |
| Peripheral mitochondrial transplantation alleviates diabetes-associated cognitive dysfunction by suppressing cuproptosis. | Brain Res Bull | 2025 | 39924054 | PubTator, text mining | PubMed |
| MT2A promotes angiogenesis in chronically ischemic brains through a copper-mitochondria regulatory mechanism. | J Transl Med | 2025 | 39915841 | PubTator, text mining | PubMed |
| Two-stage CNN-based framework for leukocytes classification. | Comput Biol Med | 2025 | 39914203 | PubTator, text mining | PubMed |
| Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth. | Nat Commun | 2025 | 39885202 | PubTator, text mining | PubMed |
| DLAT is involved in ovarian cancer progression by modulating lipid metabolism through the JAK2/STAT5A/SREBP1 signaling pathway. | Cancer Cell Int | 2025 | 39871246 | PubTator, text mining | PubMed |
| Cardiac ATP production and contractility are favorably regulated by short-term S100A9 blockade after myocardial infarction. | J Adv Res | 2025 | 39870300 | PubTator, text mining | PubMed |
| What Drives Generation Z to Avoid Food Waste in China? An Empirical Investigation. | Foods | 2025 | 39856990 | PubTator, text mining | PubMed |
| Determinants for Drunk Driving Recidivism-An Application of the Integrated Prototype Willingness Model. | Behav Sci (Basel) | 2025 | 39851852 | PubTator, text mining | PubMed |
| Identification of a novel cuproptosis inducer that induces ER stress and oxidative stress to trigger immunogenic cell death in tumors. | Free Radic Biol Med | 2025 | 39848344 | PubTator, text mining | PubMed |
| The expanded theory of planned behavior for energy saving among academics in Romania, Bulgaria, Turkey, and Slovakia. | Sci Rep | 2025 | 39843974 | PubTator, text mining | PubMed |
| A high-contrast NIR excitation probe for monitoring Cu2+ in the endoplasmic reticulum for synergistic cuproptosis and ferroptosis anticancer therapy. | Nanoscale | 2025 | 39831720 | PubTator, text mining | PubMed |
| Exploring the role of moxibustion robots in teaching: a cross-sectional study. | BMC Med Educ | 2025 | 39806354 | PubTator, text mining | PubMed |
| Exploring the impact of cuproptosis-related genes on immune infiltration in rheumatoid arthritis. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39800811 | PubTator, text mining | PubMed |
| Healthy Lifestyle Motivators of Willingness to Consume Healthy Food Brands: An Integrative Model. | Foods | 2025 | 39796415 | PubTator, text mining | PubMed |
| Metallothionein rescues doxorubicin cardiomyopathy via mitigation of cuproptosis. | Life Sci | 2025 | 39793852 | PubTator, text mining | PubMed |
| Exploring the determinants to accept dementia screening among patients at high risk of dementia based on the theory of planned behavior: A cross-sectional study. | Prev Med | 2025 | 39793765 | PubTator, text mining | PubMed |
| Sensitivity of renal cell carcinoma to cuproptosis: a bioinformatics analysis and experimental verification. | J Cancer | 2025 | 39781354 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=15